TRI-CON 2016 San Francisco, CA, Booth #222 - March 6-11, 2016
Attracting over 3,300 drug discovery and development professionals from over 40 countries in 2015, the Tri-Conference has grown into a diverse event, focusing on Molecular Medicine, specifically on Discovery, Genomics, Diagnostics and Information Technology.
With a 23 year history, this year’s expanded coverage includes additional programs on Molecular Diagnostics for Infectious Disease, Precision Medicineand Cancer Immunotherapy, as well as two new symposia on Companion Diagnostics and the Commercialization of Molecular Diagnostics.
MiniFAB's CEO Dr Erol Harvey will be giving a presentation at the Symposia on 'Microfluidic-Enabled Sample Collection Strategies for PoC Diagnostics'.
Find out more about TRI-CON 2016.